Pandemics: Prediction, Prevention, and Response
Recent efforts to forecast the next infectious disease outbreak and steps labs can take to ensure they’re prepared.
Recent efforts to forecast the next infectious disease outbreak and steps labs can take to ensure they’re prepared.
Crystal Girod, MSc, of Beckman Coulter Life Sciences discusses recent developments in NGS and their impact on clinical diagnostics.
Artificial intelligence won’t take your job—but what are the real concerns around healthcare AI and its use?
Genomic sequencing is almost twice as likely to yield a diagnostic result, but lags behind panel testing in speed, cost, and concordance.
Tackling the challenges of “forever chemicals” in the diagnostics industry.
Health inequities and disrupted STI testing and care during the pandemic continued to contribute to a rise in cases in 2021.
Recently released NGS systems will be helpful to researchers but are unlikely to immediately impact diagnostics, expert says.
G2 Intelligence managing editor Rachel Muenz chats with lab leader Stephanie Whitehead about recent developments affecting clinical labs.
The panel recently said there was still not enough evidence to properly assess the harms and benefits of such screening.
A recent CDC report concludes that disruptions to HIV testing due to the COVID-19 pandemic compromised America’s ability to prevent the disease.
According to a recent OIG report, fewer Medicare Part B beneficiaries received lab tests during the first 10 months of the pandemic.